Abstract
Nav1.7 entered the scene a decade ago as a pain target with wide-ranging analgesic effects, but it has been difficult to selectively target. Now, a team at Duke has succeeded with an antibody that blocks the channel in a closed state. The team is developing the antibody for pain and pruritus.
Cite
CITATION STYLE
APA
Martz, L. (2014). Nav-i-gating antibodies for pain. Science-Business EXchange, 7(23), 662–662. https://doi.org/10.1038/scibx.2014.662
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free